Novo Nordisk Stock Forecast 2026–2030 | Future Outlook
Novo Nordisk (NVO) is trading around $47.61 per share in intraday action, within a session range of $47.26–$48.47 based on Capital.com pricing as of 3.39pm UTC on 3 December 2025, with client positioning skewed toward buyers. The move follows a period of volatility that saw the stock approach multi-year lows in late November, as the market continued to process company-specific developments and broader sector trends.
The current session comes amid ongoing reaction to late-November updates on semaglutide Alzheimer’s trials, which outlined that key studies did not meet their primary endpoints (Reuters, 24 November 2025). At the same time, the company’s reported nine-month 2025 sales and operating-profit growth remain in focus (Novo…
